Avestar Capital’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-45,267
Closed -$1.2M 427
2021
Q4
$1.2M Sell
45,267
-7,286
-14% -$194K 0.15% 141
2021
Q3
$1.41M Buy
52,553
+509
+1% +$13.7K 0.18% 138
2021
Q2
$1.41M Buy
52,044
+1,597
+3% +$43.1K 0.19% 137
2021
Q1
$1.36M Buy
50,447
+3,675
+8% +$99.5K 0.3% 70
2020
Q4
$1.28M Buy
46,772
+2,218
+5% +$60.3K 0.36% 57
2020
Q3
$1.21M Buy
44,554
+4,505
+11% +$122K 0.4% 47
2020
Q2
$1.08M Buy
40,049
+5,784
+17% +$152K 0.48% 52
2020
Q1
$856K Buy
+34,265
New +$883K 0.47% 52

Other funds holding IBDQ

Avestar Capital's IBDQ Position: Q1 2022 in Review

Avestar Capital sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q1 2022, closing a stake of 45,267 shares — an estimated $1.2M sold.

Avestar Capital first reported a position in IBDQ in Q1 2020 and held it in 8 quarters. The position peaked at $1.41M in Q3 2021. 175 funds tracked by Wall St. Rank hold IBDQ as of Q1 2022.

  • Avestar Capital reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q1 2022 after selling out during the quarter.
  • Avestar Capital sold 45,267 iShares iBonds Dec 2025 Term Corporate ETF shares in Q1 2022, an estimated $1.2M.
  • Avestar Capital first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2020 and held it in 8 quarters.
  • Avestar Capital's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $1.41M in Q3 2021.
  • 175 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q1 2022.

Based on Avestar Capital's 13F filing for Q1 2022, filed 26 Apr 2022.